Literature DB >> 32868229

Selinexor, Bortezomib, and Dexamethasone for Heavily Pretreated Multiple Myeloma: A Case Series.

Hila Magen1, Mika Geva2, Yulia Volchik3, Abraham Avigdor2, Arnon Nagler2.   

Abstract

Entities:  

Keywords:  Heavily treated patients; Hematologic malignancies; Relapsing/refractory multiple myeloma; Selective inhibitor of nuclear export; Treatment response

Year:  2020        PMID: 32868229     DOI: 10.1016/j.clml.2020.07.016

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


× No keyword cloud information.
  1 in total

1.  Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients.

Authors:  Michel Delforge; Jolien Raddoux; Corine Antonis; Céline Clement; Nicolas Kint; Anneleen Vanhellemont; Julie Bravetti; Peter Vandenberghe
Journal:  Onco Targets Ther       Date:  2022-03-14       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.